HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Cannabis Inhaler Could Spread Use of Medical Marijuana

By HospiMedica International staff writers
Posted on 25 May 2015
Image: The Syqe Exo Inhaler device (Photo courtesy of Syqe Medical).
Image: The Syqe Exo Inhaler device (Photo courtesy of Syqe Medical).
An innovative portable thermal-metered-dose inhaler (tMDI) for Cannabis provides doctors with the ability to supervise the medical marijuana process.

The Syqe Inhaler is a pocket-sized device that utilizes selective dosing, real-time thermal and flow controllers, lung interfacing, and wireless connectivity to deliver a metered dose of tetrahydrocannabinol (THC), allowing patients to reach an optimum balance between symptom relief and psychoactivity. The platform is further comprised of proprietary raw Cannabis structural-modification methods, uniquely identified preloaded cartridges, and a linked clinical database that serves physicians, researchers, and healthcare entities.

Also available is the Syqe Inhaler Exo, which delivers a fixed 100 microgram dose of Cannabis for professional healthcare use. The Exo features a caregiver interface for nurses and other certified caregivers in hospital pain clinics, cancer centers, intensive care units (ICUs), and other medical institutions. Both inhalers differ from traditional vaporizers by using granules that contain standardized portions of whole Cannabis, in sizes as small as 1 mg. Device connectivity further helps monitor use and determine best dosages for different conditions.

Uniquely, 75% of the parts of the Syqe Inhaler prototype devices were printed on Stratasys (Rehovot, Israel) three dimensional (3D) printers, a convenience that sped up the manufacturing process. The Syqe Inhaler and the Syqe Inhaler Exo are products of Syqe Medical (Tel Aviv, Israel) and have been authorized for use in Israel since October 2014.

“Different materials were selected for the four main components of the device - the shell, chassis, airway, and thermal housing, which allowed them to have rigidity, clarity, biocompatibility, and heat resistance for the inhaler,” said Perry Davidson, CEO of Syqe Medical. “Since metered dose inhalation of raw botanicals is a highly unconventional undertaking, we had to develop the tooling and machines for many of our processes. More than half of our production equipment, jigs, and analytical tools were printed in house.”

Related Links:

Syqe Medical


Gold Member
CPAP Ventilator
Somnus DM18
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Head Rest
Medifa 61114_3

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more